The detailed 3D docking and interaction analyses revealed that thymol contained favorable binding sites for SLC6A3, ACHE, and JAK1, supporting their roles as key active compounds in treating POF (Figure 2). This evidence concerns the gene SLC6A3 and premature menopause.